Myths and Misconceptions of Medication-Assisted Treatment
This web page discusses the myths and misconceptions of medication-assisted treatment for individuals with a substance use disorder.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
This web page discusses the myths and misconceptions of medication-assisted treatment for individuals with a substance use disorder.
Provides information for pregnant women about how taking methadone or buprenorphine may affect delivery, breastfeeding, and newborn infants.
Offers guidance on the use of MAT with extended-release injectable naltrexone for the treatment of OUD. Covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment.
Provides an overview of the key points of the National Practice Guideline, detailed recommendations for OUD diagnosis, and information on treatment settings and opioid withdrawal. Describes MAT options and considerations for treating special populations. Links to additional resources, such as a pocket guide and a slide deck.
Highlights the use of MAT for opioid use disorder in drug courts, reviews effective medications, and provides strategies to increase the use of MAT in drug court programs.
MCPAP for Moms provides obstetricians, midwives, and PCPs with psychiatric consultation for behavioral health concerns and questions around medications when pregnant or breastfeeding. MCPAP for Moms also supports connections with community-based services and support groups.